A detailed history of Harel Insurance Investments & Financial Services Ltd. transactions in Teva Pharmaceutical Industries LTD stock. As of the latest transaction made, Harel Insurance Investments & Financial Services Ltd. holds 25,751 shares of TEVA stock, worth $435,964. This represents 0.01% of its overall portfolio holdings.

Number of Shares
25,751
Previous 28,533,099 99.91%
Holding current value
$435,964
Previous $298 Million 99.88%
% of portfolio
0.01%
Previous 5.24%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 30, 2024

SELL
$10.67 - $14.43 $304 Million - $411 Million
-28,507,348 Reduced 99.91%
25,751 $363,000
Q4 2023

Jan 30, 2024

BUY
$8.12 - $10.63 $6.67 Million - $8.74 Million
821,759 Added 2.97%
28,533,099 $298 Million
Q3 2023

Oct 30, 2023

BUY
$7.48 - $10.7 $207 Million - $296 Million
27,696,340 Added 184642.27%
27,711,340 $283 Million
Q2 2023

Jul 17, 2023

SELL
$7.2 - $9.47 $168 Million - $220 Million
-23,283,179 Reduced 99.94%
15,000 $114,000
Q1 2023

May 02, 2023

BUY
$8.36 - $11.37 $68.4 Million - $93 Million
8,179,950 Added 54.11%
23,298,179 $206 Million
Q4 2022

Jan 26, 2023

BUY
$7.95 - $9.48 $7.83 Million - $9.34 Million
985,502 Added 6.97%
15,118,229 $138 Million
Q3 2022

Oct 31, 2022

BUY
$6.86 - $11.95 $18.4 Million - $32.1 Million
2,685,200 Added 23.46%
14,132,727 $114 Million
Q2 2022

Jul 19, 2022

BUY
$7.38 - $10.4 $7.16 Million - $10.1 Million
970,800 Added 9.27%
11,447,527 $86.1 Million
Q1 2022

May 03, 2022

BUY
$7.33 - $9.39 $3.92 Million - $5.02 Million
535,000 Added 5.38%
10,476,727 $98.4 Million
Q4 2021

Feb 07, 2022

SELL
$7.9 - $10.19 $779,572 - $1.01 Million
-98,680 Reduced 0.98%
9,941,727 $79.6 Million
Q3 2021

Oct 25, 2021

BUY
$8.38 - $10.18 $838,000 - $1.02 Million
100,000 Added 1.01%
10,040,407 $97.8 Million
Q2 2021

Jul 26, 2021

SELL
$9.9 - $11.56 $198,000 - $231,200
-20,000 Reduced 0.2%
9,940,407 $98.6 Million
Q1 2021

Apr 27, 2021

BUY
$10.34 - $12.81 $6.87 Million - $8.51 Million
664,600 Added 7.15%
9,960,407 $116 Million
Q4 2020

Jan 26, 2021

BUY
$8.61 - $11.04 $10.4 Million - $13.3 Million
1,205,229 Added 14.9%
9,295,807 $89.9 Million
Q3 2020

Oct 20, 2020

BUY
$8.57 - $12.69 $4.06 Million - $6.01 Million
473,526 Added 6.22%
8,090,578 $72.9 Million
Q2 2020

Jul 14, 2020

BUY
$8.12 - $13.12 $8.83 Million - $14.3 Million
1,087,530 Added 16.66%
7,617,052 $93.9 Million
Q1 2020

Apr 28, 2020

BUY
$6.69 - $13.45 $7.9 Million - $15.9 Million
1,181,309 Added 22.09%
6,529,522 $58.6 Million
Q4 2019

Jan 23, 2020

BUY
$6.53 - $10.72 $34.9 Million - $57.3 Million
5,348,213 New
5,348,213 $52.4 Million
Q3 2019

Nov 06, 2019

SELL
$6.16 - $9.6 $32.9 Million - $51.3 Million
-5,348,213 Closed
0 $0
Q2 2019

Jul 22, 2019

BUY
$8.12 - $15.72 $215,991 - $418,152
26,600 Added 0.5%
5,348,213 $49.4 Million
Q1 2019

Apr 18, 2019

SELL
$15.58 - $20.01 $6.14 Million - $7.88 Million
-393,886 Reduced 6.89%
5,321,613 $83.4 Million
Q4 2018

Jan 29, 2019

BUY
$14.59 - $23.84 $41.7 Million - $68.1 Million
2,855,802 Added 99.86%
5,715,499 $88.1 Million
Q3 2018

Oct 29, 2018

BUY
$21.06 - $25.65 $22.4 Million - $27.3 Million
1,063,551 Added 59.21%
2,859,697 $61.6 Million
Q2 2018

Jul 30, 2018

SELL
$16.77 - $24.71 $4.81 Million - $7.09 Million
-286,880 Reduced 13.77%
1,796,146 $43.7 Million
Q1 2018

Apr 30, 2018

SELL
$16.68 - $22.07 $16.6 Million - $22 Million
-996,980 Reduced 32.37%
2,083,026 $35.6 Million
Q4 2017

Feb 01, 2018

BUY
$11.23 - $19.1 $6.07 Million - $10.3 Million
540,669 Added 21.29%
3,080,006 $45.9 Million
Q3 2017

Nov 02, 2017

BUY
$15.41 - $32.17 $39.1 Million - $81.7 Million
2,539,337
2,539,337 $44.7 Million

Others Institutions Holding TEVA

About TEVA PHARMACEUTICAL INDUSTRIES LTD


  • Ticker TEVA
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,110,560,000
  • Market Cap $18.8B
  • Description
  • Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...
More about TEVA
Track This Portfolio

Track Harel Insurance Investments & Financial Services Ltd. Portfolio

Follow Harel Insurance Investments & Financial Services Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Harel Insurance Investments & Financial Services Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Harel Insurance Investments & Financial Services Ltd. with notifications on news.